Ishikawa, Toru <br/><br/>
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.  [electronic resource] 

 -  World journal of gastroenterology  Nov 2007 
 - 5465-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1007-9327 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v13.i41.5465  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Hepatocellular--complications<br/>Chemotherapy, Cancer, Regional Perfusion<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Infusions, Intra-Arterial<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--complications<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Pilot Projects<br/>Portal Vein--pathology<br/>Prospective Studies<br/>Severity of Illness Index<br/>Tablets, Enteric-Coated<br/>Tegafur--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Uracil--administration & dosage<br/>Venous Thrombosis--drug therapy